Multiple newly identified loci associated with prostate cancer susceptibility
Douglas F. Easton(University of Cambridge), Sarah Jugurnauth(Institute of Cancer Research), Daniel Leongamornlert(University of Southern California), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Freddie C. Hamdy(University of Oxford), Dallas R. English, Graham G. Giles(The University of Melbourne), John L. Hopper(The University of Melbourne), Kenneth Muir(Manchester Academic Health Science Centre), Amanda L. Hall(University of Newcastle Australia), Sameer Jhavar(National Cancer Institute), Jonathan J. Morrison(Uniformed Services University of the Health Sciences), Robert Huddart(Institute of Cancer Research), Chris Ogden(Royal Marsden NHS Foundation Trust), Ali Amin Al Olama(Institute of Cancer Research), Jenny Donovan(At Bristol), S. Grant Mulholland(Institute of Cancer Research), Zsofia Kote‐Jarai(Institute of Cancer Research), Audrey Ardern‐Jones(Royal Marsden NHS Foundation Trust), Rosemary Wilkinson(Institute of Cancer Research), Alan Horwich(Institute of Cancer Research), Alan J. Thompson(Queen Mary University of London), Sarah L. Bryant(Royal Marsden NHS Foundation Trust), Vincent Khoo(The University of Texas MD Anderson Cancer Center), Melisa Bagnato(Royal Marsden NHS Foundation Trust), Cyril Fisher(Royal Marsden Hospital), Beatrice N. Gehr-Swain(Royal Marsden NHS Foundation Trust), Malgorzata Tymrakiewicz(Institute of Cancer Research), Melissa C. Southey(The University of Melbourne), Gianluca Severi(Inserm), David E. Neal(University of Cambridge), Paul Brown(Institute of Cancer Research), Charmaine Smith(Royal Marsden NHS Foundation Trust), Charles Jamieson(Royal Marsden NHS Foundation Trust), Colin S. Cooper(Institute of Cancer Research), David Dearnaley(Royal Marsden NHS Foundation Trust), Michelle Guy(Institute of Cancer Research), Artitaya Lophatananon(University of Warwick), Christopher Woodhouse(Royal Marsden NHS Foundation Trust), Stephen M. Edwards(Institute of Cancer Research), Christopher Parker(Royal Marsden NHS Foundation Trust), Tim Christmas(Royal Marsden NHS Foundation Trust), Helen I. Field(Rockefeller University), Sarah J. Lewis(University of Bristol), Lynne T. O'Brien(Institute of Cancer Research)
Cited by 850
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k